Please assess the completion status of the following clinical trial:

Trial Title: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients ≥ 20 years old~* Patients who are hospitalized and expected to undergo PCI for acute coronary syndrome, including acute myocardial infarction and unstable angina.~Exclusion Criteria:~* Age \> 80 years~* Cardiogenic shock or unstable patients~* Increased risk of bleeding, anemia, thrombocytopenia~* A need for oral anticoagulation therapy~* Pregnant women or women with potential childbearing~* Life expectancy \< 1 year

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Ticagrelor Arm (Type: EXPERIMENTAL): Ticagrelor Arm
- Clopidogrel Arm (Type: ACTIVE_COMPARATOR): Clopidogrel Arm

Based on this trial design, predict the completion outcome and termination type (if applicable).